Identification of novel targets for the diagnosis and treatment of liver fibrosis

International Journal of Molecular Medicine

Volumn 36, Issue 3, 2015, Pages 747-752

  Fagone, Paolo ^a   Mangano, Katia ^a   Mammana, Santa ^a   Pesce, Antonio ^a   Pesce, Aurora ^a   Caltabiano, Rosario ^a   Giorlandino, Alexandra ^a   Rosanna Portale, Teresa ^a   Cavalli, Eugenio ^a   Lombardo, Giuseppe A G ^a   Coco, Marinella ^a   Puleo, Stefano ^a   Nicoletti, Ferdinando ^a  

^a UNIVERSITY OF CATANIA   (Italy)

Author keywords

Bioinformatics; Hepatic fibrosis; Hepatic stellate cells; Liver; Myofibroblast

Indexed keywords

BIOLOGICAL MARKER; CALVASCULIN; GROWTH FACTOR; MATRIX METALLOPROTEINASE; TRANSCRIPTION FACTOR RUNX2;

ANIMAL CELL; ARTICLE; CELL ACTIVATION; DRUG TARGETING; EXTRACELLULAR MATRIX; FIBROGENESIS; GENE EXPRESSION; GENETIC ANALYSIS; GENETIC ASSOCIATION; LIVER FIBROSIS; MOLECULAR BIOLOGY; MOUSE; MYOFIBROBLAST; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RAT; RELIABILITY; STELLATE CELL; DOWN REGULATION; DRUG DEVELOPMENT; DRUG EFFECTS; GENE ONTOLOGY; GENE REGULATORY NETWORK; GENETICS; HUMAN; LIVER; LIVER CIRRHOSIS; METABOLISM; MOLECULARLY TARGETED THERAPY; PROCEDURES; UPREGULATION;

DOWN-REGULATION; DRUG DISCOVERY; GENE ONTOLOGY; GENE REGULATORY NETWORKS; HUMANS; LIVER; LIVER CIRRHOSIS; MOLECULAR TARGETED THERAPY; UP-REGULATION;

EID: 84938062226     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2015.2264     Document Type: Article

References (24)

1. Anthony PP, Ishak KG, Nayak NC, Poulsen HE, Scheuer PJ and Sobin LH: The morphology of cirrhosis. Recommendations on definition, nomenclature, and classification by a working group sponsored by the World Health Organization. J Clin Pathol 31: 395-414, 1978.
2. Hernandez-Gea V and Friedman SL: Pathogenesis of liver fibrosis. Annu Rev Pathol 6: 425-456, 2011.
3. Gressner AM and Weiskirchen R: Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-β as major players and therapeutic targets. J Cell Mol Med 10: 76-99, 2006.
4. Friedman SL: Hepatic stellate cells: Protean, multifunctional, and enigmatic cells of the liver. Physiol Rev 88: 125-172, 2008.
5. Tacke F and Weiskirchen R: Update on hepatic stellate cells: Pathogenic role in liver fibrosis and novel isolation techniques. Expert Rev Gastroenterol Hepatol 6: 67-80, 2012.
6. Popov Y and Schuppan D: Targeting liver fibrosis: strategies for development and validation of antifibrotic therapies. Hepatology 50: 1294-1306, 2009.
7. Schuppan D and Kim YO: Evolving therapies for liver fibrosis. J Clin Invest 123: 1887-1901, 2013.
8. Nicoletti A, Fagone P, Donzuso G, Mangano K, Dibilio V, Caponnetto S, Bendtzen K, Zappia M and Nicoletti F: Parkinson's disease is associated with increased serum levels of macrophage migration inhibitory factor. Cytokine 55: 165-167, 2011.
9. Fagone P, Di Rosa M, Palumbo M, De Gregorio C, Nicoletti F and Malaguarnera L: Modulation of heat shock proteins during macrophage differentiation. Inflamm Res 61: 1131-1139, 2012.
10. Parkinson H, Sarkans U, Kolesnikov N, Abeygunawardena N, Burdett T, Dylag M, Emam I, Farne A, Hastings E, Holloway E, et al: ArrayExpress update - an archive of microarray and high-throughput sequencing-based functional genomics experiments. Nucleic Acids Res 39 (Database issue): D1002-D1004, 2011.
11. Fagone P, Muthumani K, Mangano K, Magro G, Meroni PL, Kim JJ, Sardesai NY, Weiner DB and Nicoletti F: VGX-1027 modulates genes involved in lipopolysaccharide-induced Toll-like receptor 4 activation and in a murine model of systemic lupus erythematosus. Immunology 142: 594-602, 2014.
12. Amann T, Bataille F, Spruss T, Mühlbauer M, Gäbele E, Schölmerich J, Kiefer P, Bosserhoff AK and Hellerbrand C: Activated hepatic stellate cells promote tumorigenicity of hepatocellular carcinoma. Cancer Sci 100: 646-653, 2009.
13. Bissell DM, Wang SS, Jarnagin WR and Roll FJ: Cell-specific expression of transforming growth factor-beta in rat liver. Evidence for autocrine regulation of hepatocyte proliferation. J Clin Invest 96: 447-455, 1995.
14. Coker RK, Laurent GJ, Shahzeidi S, Lympany PA, du Bois RM, Jeffery PK and McAnulty RJ: Transforming growth factors- beta 1, - beta 2, and -beta 3 stimulate fibroblast procollagen production in vitro but are differentially expressed during bleomycin-induced lung fibrosis. Am J Pathol 150: 981-991, 1997.
15. Watanabe K, Tajino T, Sekiguchi M and Suzuki T: h-Caldesmon as a specific marker for smooth muscle tumors. Comparison with other smooth muscle markers in bone tumors. Am J Clin Pathol 113: 663-668, 2000.
16. Lawson WE, Polosukhin VV, Zoia O, Stathopoulos GT, Han W, Plieth D, Loyd JE, Neilson EG and Blackwell TS: Characterization of fibroblast-specific protein 1 in pulmonary fibrosis. Am J Respir Crit Care Med 171: 899-907, 2005.
17. Robertson H, Ali S, McDonnell BJ, Burt AD and Kirby JA: Chronic renal allograft dysfunction: The role of T cell-mediated tubular epithelial to mesenchymal cell transition. J Am Soc Nephrol 15: 390-397, 2004.
18. Rygiel KA, Robertson H, Marshall HL, Pekalski M, Zhao L, Booth TA, Jones DE, Burt AD and Kirby JA: Epithelial-mesenchymal transition contributes to portal tract fibrogenesis during human chronic liver disease. Lab Invest 88: 112-123, 2008.
19. Xie R, Schlumbrecht MP, Shipley GL, Xie S, Bassett RL Jr and Broaddus RR: S100A4 mediates endometrial cancer invasion and is a target of TGF-beta1 signaling. Lab Invest 89: 937-947, 2009.
20. Ito Y: Oncogenic potential of the RUNX gene family: overview. Oncogene 23: 4198-4208, 2004.
21. Xiao G, Jiang D, Thomas P, Benson MD, Guan K, Karsenty G and Franceschi RT: MAPK pathways activate and phosphorylate the osteoblast-specific transcription factor, Cbfa1. J Biol Chem 275: 4453-4459, 2000.
22. Hattori S, Dhar DK, Hara N, Tonomoto Y, Onoda T, Ono T, Yamanoi A, Tachibana M, Tsuchiya M and Nagasue N: FR-167653, a selective p38 MAPK inhibitor, exerts salutary effect on liver cirrhosis through downregulation of Runx2. Lab Invest 87: 591-601, 2007.
23. Ji J, Yu F, Ji Q, Li Z, Wang K, Zhang J, Lu J, Chen L, E Q, Zeng Y and Ji Y: Comparative proteomic analysis of rat hepatic stellate cell activation: A comprehensive view and suppressed immune response. Hepatology 56: 332-349, 2012.
24. Rasche A, Al-Hasani H and Herwig R: Meta-analysis approach identifies candidate genes and associated molecular networks for type-2 diabetes mellitus. BMC Genomics 9: 310, 2008.